Abstract：MonoMAC syndrome is a newly discovered immune deficiency syndrome caused by GATA-2 mutation, which is an autosomal dominant genetic disease. MonoMAC syndrome has typical immune cell abnormalities, with severe infection and is prone to develop into a hematological disease. Therapeutics for this disease mainly relies on symptomatic treatment and hematopoietic stem cell transplantation. In this paper, the research advances in clinical manifestations, laboratory tests, pathogenesis, diagnosis and treatment of MonoMAC syndrome are reviewed.
Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome[J]. Blood, 2011, 118(10): 2653-2655.
[2]
Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia[J]. Blood, 2010, 115(8): 1519-1529.
[3]
Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency[J]. J Exp Med, 2011, 208(2): 227-234.
[4]
Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications[J]. Haematologica, 2011, 96(8): 1221-1225.
[5]
Randolph GJ, Jakubzick C, Qu C. Antigen presentation by monocytes and monocyte-derived cells[J]. Curr Opin Immunol, 2008, 20(1): 52-60.
[6]
Villadangos JA. Hold on, the monocytes are coming![J]. Immunity, 2007, 26(4): 390-392.
[7]
Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)[J]. Nature Genet, 2011, 43(10): 929-931.
[8]
Gumina RJ, Kirschbaum NE, Piotrowski K, et al. Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity[J]. Blood, 1997, 89(4): 1260-1269.
[9]
Kappel A, Schlaeger TM, Flamme I, et al. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development[J]. Blood, 2000, 96(9): 3078-3085.
[10]
Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature[J]. Blood, 2012, 119(5): 1283-1291.
Murphy J, Summer R, Wilson AA, et al. The prolonged life-span of alveolar macrophages[J]. Am J Resp Cell Mol Biol, 2008, 38(4): 380.
[13]
Haniffa M, Ginhoux F, Wang XN, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation[J]. J Exp Med, 2009, 206(2): 371-385.
[14]
Mace EM, Hsu AP, Monaco-Shawver L, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset[J]. Blood, 2013, 121(14): 2669-2677.
[15]
McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells[J]. Blood, 2000, 95(11): 3489-3497.
[16]
Ishida H, Imai K, Honma K, et al. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B-and NK-cell (DCML) deficiency, and myelodysplasia[J]. Eur J Pediatr, 2012, 171(8): 1273-1276.
[17]
Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency[J]. Blood, 2011, 118(10): 2656-2658.
[18]
Pedone PV, Omichinski JG, Nony P, et al. The N-terminal fingers of chicken GATA-2 and GATA–3 are independent sequence-specific DNA binding domains[J]. EMBO J, 1997, 16(10): 2874-2882.
[19]
Rodrigues NP, Tipping AJ, Wang Z, et al. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia[J]. Int J Biochem Cell Biol, 2012, 44(3): 457-460.
[20]
Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2[J]. Nature, 1994, 371(6494): 221-226.
[21]
Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation[J]. Blood, 1997, 89(10): 3636-3643.
[22]
Ikonomi P, Noguchi CT, Miller W, et al. Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins[J]. Gene, 2000, 261(2): 277-287.
[23]
Persons DA, Allay JA, Allay ER, et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis[J]. Blood, 1999, 93(2): 488-499.
[24]
Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis[J]. Blood, 2005, 106(2): 477-484.
Tong Q, Tsai J, Tan G, et al. Interaction between GATA and the C/EBP family of transcription factors is critical in GATAmediated suppression of adipocyte differentiation[J]. Mol Cell Biol, 2005, 25(2): 706-715.
[27]
Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia[J]. Nature Genet, 2011, 43(10): 1012-1017.
[28]
Vicente C, Vazquez I, Conchillo A, et al. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities[J]. Leukemia, 2011, 26(3): 550-554.
[29]
Böhm M, Locke WJ, Sutherland RL, et al. A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes[J]. Oncogene, 2009, 28(43): 3847-3856.
Huang Z, Dore L C, Li Z, et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1[J]. Mol Cell Biol, 2009, 29(18): 5168-5180.
[32]
Hsu AP, Johnson KD, Falcone EL, et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome[J]. Blood, 2013, 121(19): 3830-3837.
[33]
Cuellar-Rodriguez J, Gea-Banacloche J, Freeman A F, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency[J]. Blood, 2011, 118(13): 3715-3720.
